HS Icon Composite diagnostic or laboratory reagents, including COVID-19 Test kits based on polymerase chain reaction (PCR) nucleic acid test

382200 (Harmonized System 1992 for 6-digit)

World Trade (2018): $27.1B, Rnk 93 / 4726

Top Exporter (2018): $7.05B, United States

Top Importer (2018): $3.49B, United States

Product Complexity (2018): 0.69, Rnk 777 / 2722

Export Growth (CAGR)(2017 - 2018): 7.4%, Rnk 3046 / 4726

Mean Tariff (2018): 3.43%, Rnk 5451 / 6538

Share of World Trade (2018): 0.15%, Rnk 93 / 4726

Overview:  This page contains the latest trade data of Composite diagnostic or laboratory reagents, including COVID-19 Test kits based on polymerase chain reaction (PCR) nucleic acid test. In 2018, Composite diagnostic or laboratory reagents, including COVID-19 Test kits based on polymerase chain reaction (PCR) nucleic acid test were the world's 93rd most traded product, with a total trade of $27.1B. Between 2017 and 2018 the exports of Composite diagnostic or laboratory reagents, including COVID-19 Test kits based on polymerase chain reaction (PCR) nucleic acid test grew by 7.4%, from  $25.2B to $27.1B. Trade in Composite diagnostic or laboratory reagents, including COVID-19 Test kits based on polymerase chain reaction (PCR) nucleic acid test represent 0.15% of total world trade.

Exports: In 2018 the top exporters of Composite diagnostic or laboratory reagents, including COVID-19 Test kits based on polymerase chain reaction (PCR) nucleic acid test  were United States ($7.05B), Germany ($4.46B), United Kingdom ($2.04B), Netherlands ($1.92B), and France ($1.35B).

Imports: In 2018 the top importers of Composite diagnostic or laboratory reagents, including COVID-19 Test kits based on polymerase chain reaction (PCR) nucleic acid test were United States ($3.49B), Germany ($3.1B), China ($2.18B), Netherlands ($1.58B), and France ($1.47B).

Tariffs: In 2018 the average tariff for Composite diagnostic or laboratory reagents, including COVID-19 Test kits based on polymerase chain reaction (PCR) nucleic acid test was 3.43%, making it the 5451st lowest tariff using the HS6 product classification.

The countries with the highest import tariffs for Composite diagnostic or laboratory reagents, including COVID-19 Test kits based on polymerase chain reaction (PCR) nucleic acid test are Bermuda (25%), Pakistan (19.5%), Azerbaijan (14.4%), Algeria (12.2%), and Aruba (12%). The countries with the lowest tariffs are Angola (0%), Cote d'Ivoire (0%), Ghana (0%), Guinea (0%), and Kenya (0%).

Ranking: Composite diagnostic or laboratory reagents, including COVID-19 Test kits based on polymerase chain reaction (PCR) nucleic acid test ranks 777th in the Product Complexity Index (PCI).

Description: Composite diagnostic reagents are diagnostic reagents that detect multiple analytes. Common types of composite diagnostic reagents are ELISA, Western blot, and immunohistochemistry. Laboratory reagents are the materials, chemicals, compounds, or substances used in the laboratory. Common types of laboratory reagents are agarose, sodium chloride, ammonium hydroxide, and hydrogen peroxide.

Exporters and Importers

#permalink to section

Trade By Country

Top Origin (2018): United States, $7.05B

Top Destination (2018): United States, $3.49B

Composite diagnostic or laboratory reagents, including COVID-19 Test kits based on polymerase chain reaction (PCR) nucleic acid test are the world's 93rd most traded product.

In 2018, the top exporters of Composite diagnostic or laboratory reagents, including COVID-19 Test kits based on polymerase chain reaction (PCR) nucleic acid test were United States ($7.05B), Germany ($4.46B), United Kingdom ($2.04B), Netherlands ($1.92B), and France ($1.35B).

In 2018, the top importers of Composite diagnostic or laboratory reagents, including COVID-19 Test kits based on polymerase chain reaction (PCR) nucleic acid test were United States ($3.49B), Germany ($3.1B), China ($2.18B), Netherlands ($1.58B), and France ($1.47B).

Explore Visualizations

Market Dynamics

#permalink to section

Trade by country

Value

Top Origin Growth (2017 -  2018): Netherlands, $738M

Top Destination Growth (2017 - 2018): China, $461M

Between 2017 and 2018, the exports of Composite diagnostic or laboratory reagents, including COVID-19 Test kits based on polymerase chain reaction (PCR) nucleic acid test grew the fastest in Netherlands ($738M), United States ($377M), Ireland ($339M), Lithuania ($270M), and Singapore ($209M).

Between 2017 and 2018, the fastest growing importers of Composite diagnostic or laboratory reagents, including COVID-19 Test kits based on polymerase chain reaction (PCR) nucleic acid test were China ($461M), Brazil ($289M), Japan ($235M), Netherlands ($222M), and United States ($175M).

Explore Visualizations

Market Concentration

#permalink to section

Cumulative market share

This chart shows the evolution of the market concentration of exports of Composite diagnostic or laboratory reagents, including COVID-19 Test kits based on polymerase chain reaction (PCR) nucleic acid test.

In 2018,  market concentration measured using Shannon Entropy, was 3.93. This means that most of the exports of Composite diagnostic or laboratory reagents, including COVID-19 Test kits based on polymerase chain reaction (PCR) nucleic acid test are explained by 15 countries.

Explore Visualizations

TOP NET EXPORTER (2018): United States, $3.56B

TOP NET IMPORTER (2018): China, $1.68B

This map shows which countries export or import more of Composite diagnostic or laboratory reagents, including COVID-19 Test kits based on polymerase chain reaction (PCR) nucleic acid test. Each country is colored based on the difference in exports and imports of Composite diagnostic or laboratory reagents, including COVID-19 Test kits based on polymerase chain reaction (PCR) nucleic acid test during 2018.

In 2018, the countries that had a largest trade value in exports than in imports of Composite diagnostic or laboratory reagents, including COVID-19 Test kits based on polymerase chain reaction (PCR) nucleic acid test were United States ($3.56B), Germany ($1.36B), United Kingdom ($901M), Ireland ($776M), and Singapore ($695M).

In 2018, the countries that had a largest trade value in imports than in exports of Composite diagnostic or laboratory reagents, including COVID-19 Test kits based on polymerase chain reaction (PCR) nucleic acid test were China ($1.68B), Italy ($617M), Brazil ($419M), India ($347M), and Saudi Arabia ($335M).

Import Tariffs

#permalink to section

In 2018, the average tariff for importing Composite diagnostic or laboratory reagents, including COVID-19 Test kits based on polymerase chain reaction (PCR) nucleic acid test was 3.43%.  The countries with the highest tariffs for importing Composite diagnostic or laboratory reagents, including COVID-19 Test kits based on polymerase chain reaction (PCR) nucleic acid test were Bermuda (25%), Pakistan (19.5%), Azerbaijan (14.4%), Algeria (12.2%), and Aruba (12%).

Explore Tariff Data

Product Complexity

#permalink to section

Diversification Frontier

#permalink to section
Filter

The Complexity-Relatedness diagram compares the risk and the strategic value of a product's potential export opportunities. Relatedness is predictive of the probability that a country increases its exports in a product. Complexity, is associated with higher levels of income, economic growth potential, lower income inequality, and lower emissions.